4400 BISCAYNE BLVD., MIAMI, FL
Reports Third Quarter 2025 Business Highlights and Financial Results
Completes Acquisition of Select Assets of Innovative Oncology and Related Clinical Testing Services Businesses
Earnings Release
Changes in Board, Management or Compensation
Shareholder votes
Material disclosure
Annual Report to Security Holders
Q3
Q2
Q1
Amended Annual Report
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus Filed Pursuant to Rule 424(b)(2)
S-3ASR
Registration of Securities
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Definitive Revised Proxy Statement
Amended Notice of Proposed Sale of Securities
Prospectus filed pursuant to Rule 424(b)(7)
Free Writing Prospectus